Mode
Text Size
Log in / Sign up
Phase 4 N=65 Randomized Treatment

Pressure Ulcer Healing With Microcyn

Pressure Ulcer · Spinal Cord Injuries

Enrolled (actual)
65
Serious AEs
0.0%
Results posted
Nov 2018
Primary outcome: Primary: Pressure Ulcer Size (Length x Width x Depth, cm^3) at Baseline — 10.13; 21.00 cm^3

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Microcyn (Drug); Sterile saline (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Alabama at Birmingham
Primary completion
Aug 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Pressure Ulcer Size (Length x Width x Depth, cm^3) at Baseline
10.13; 21.00
PRIMARY
Pressure Ulcer Size (Length x Width x Depth, cm^3) at 4 Weeks After Baseline
9.00; 15.75
PRIMARY
Pressure Ulcer Size (Length x Width x Depth, cm^3) at 8 Weeks After Baseline
10.00; 20.06
PRIMARY
Pressure Ulcer Size (Length x Width x Depth, cm^3) at 12 Weeks After Baseline
7.50; 19.25
PRIMARY
Pressure Ulcer Size (Length x Width x Depth, cm^3) at 16 Weeks After Baseline
8.00; 11.63
PRIMARY
Pressure Ulcer Size (Length x Width x Depth, cm^3) at 20 Weeks After Baseline
7.63; 9.75
PRIMARY
Pressure Ulcer Size (Length x Width x Depth, cm^3) at 24 Weeks After Baseline
3.68; 8.68
SECONDARY
Pressure Ulcer Scale for Healing (PUSH) Score
12.00; 12.00
SECONDARY
Pressure Ulcer Scale for Healing (PUSH) Score at 4 Weeks After Baseline
12.00; 11.00
SECONDARY
Pressure Ulcer Scale for Healing (PUSH) Score at 8 Weeks After Baseline
11.00; 11.50
SECONDARY
Pressure Ulcer Scale for Healing (PUSH) Score at 12 Weeks After Baseline
10.00; 11.50
SECONDARY
Pressure Ulcer Scale for Healing (PUSH) Score at 16 Weeks After Baseline
12.00; 11.50
SECONDARY
Pressure Ulcer Scale for Healing (PUSH) Score at 20 Weeks After Baseline
11.00; 10.50
SECONDARY
Pressure Ulcer Scale for Healing (PUSH) Score at 24 Weeks After Baseline
10.50; 11.00

Summary

The purpose of this study is to test how well Microcyn™ works on Stage 3 and Stage 4 pressure ulcers compared to sterile saline among persons with spinal cord injury.

Eligibility Criteria

Inclusion Criteria

  • Age > 17 years
  • Persons with spinal cord injury
  • Having Stage III/IV pressure ulcer(s)
  • Able to fulfill all obligations of the study

Exclusion Criteria

  • Pressure ulcers scheduled for surgical closure within 14 days
  • Use of any immunosuppressant medications within 30 days of screening
  • Having conditions that put the subject at significant risk
  • Medically unstable or has a life expectancy of less than 12 months
  • Current enrollment in an investigational drug or device study or participation in such a study within the last 30 days
  • Pregnant women
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02001558). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search